Publication details

Impact of narrow band imaging in prediction of histology of advanced colorectal neoplasia

Authors

GREGA Tomas KMOCHOVA Klara HEJCMANOVÁ Kateřina NGO Ondřej BRODYUK Nadija MÁJEK Ondřej BURES Jan URBANEK Petr ZAVORAL Miroslav SUCHÁNEK Štěpán

Year of publication 2025
Type Article in Periodical
Magazine / Source Scientific Reports
MU Faculty or unit

Faculty of Medicine

Citation
web https://www.nature.com/articles/s41598-025-85669-w
Doi http://dx.doi.org/10.1038/s41598-025-85669-w
Keywords Colonoscopy; Narrow-band imaging; Colon tumour; Diagnostic accuracy; JNET classification; NICE classification
Description We assessed the diagnostic performance of the Narrow-Band Imaging (NBI) International Colorectal Endoscopic Classification (NICE) and the Japan NBI Expert Team classification (JNET) in predicting histological outcomes of advanced colorectal lesions. Additionally, we evaluated the sensitivity and positive predictive value (PPV) of the JNET and NICE classifications individually for high-grade lesions (including HGD adenomas, intramucosal carcinomas, and T1 carcinomas). This was a retrospective analysis of prospectively collected data, involving 211 patients (130 men, mean age 60 years) who underwent colonoscopy with endoscopic resection of advanced colorectal neoplasia (lesions >= 10 mm). Lesions were classified using both NICE and JNET criteria, and final histopathological results were used for comparison. Of the 257 lesions analyzed, the NICE classification accurately classifies a large proportion of lesions (93.8%). In JNET classification we observed 77.4% correctly classified lesions. Specifically, the sensitivity and positive predictive value (PPV) of the NICE classification for high-grade lesions were 100% and 24.4%, respectively. For the JNET classification, the sensitivity and PPV for high-grade lesions were 56.6% and 57.7%, respectively. The JNET classification, with a positive predictive value of 57.7% for high-grade colorectal lesions (including HGD adenomas, intramucosal carcinomas, and T1 carcinomas), should be used for decision-making regarding appropriate subsequent endoscopic therapy.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info